Astellas Pharma Inc.
Astellas Pharma Inc. (ALPMY) Stock Competitors & Peer Comparison
See (ALPMY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALPMY | $15.10 | -2.14% | 27B | 34.20 | $0.44 | +2.91% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.29% |
| RHHBF | $419.50 | +0.00% | 333.9B | 20.53 | $20.43 | +3.04% |
| RHHBY | $51.22 | -0.81% | 329.2B | 19.96 | $2.56 | +3.11% |
| RHHVF | $403.29 | +8.69% | 321B | 19.92 | $20.25 | +3.09% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $145.00 | -0.02% | 276.7B | 20.31 | $7.14 | +3.28% |
| SNYNF | $95.06 | +2.83% | 114.1B | 20.53 | $4.63 | +4.61% |
| GLAXF | $26.87 | -1.26% | 105.4B | 14.12 | $1.87 | +3.34% |
| CHGCF | $45.84 | -15.28% | 78.9B | 28.88 | $1.66 | +3.76% |
Stock Comparison
ALPMY vs BMYMP Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, ALPMY is priced at $15.10, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, ALPMY's ROE is +0.20%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, ALPMY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check BMYMP's competition here
ALPMY vs RHHBF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, RHHBF has a market cap of 333.9B. Regarding current trading prices, ALPMY is priced at $15.10, while RHHBF trades at $419.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas RHHBF's P/E ratio is 20.53. In terms of profitability, ALPMY's ROE is +0.20%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, ALPMY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check RHHBF's competition here
ALPMY vs RHHBY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, RHHBY has a market cap of 329.2B. Regarding current trading prices, ALPMY is priced at $15.10, while RHHBY trades at $51.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas RHHBY's P/E ratio is 19.96. In terms of profitability, ALPMY's ROE is +0.20%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, ALPMY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check RHHBY's competition here
ALPMY vs RHHVF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, ALPMY is priced at $15.10, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas RHHVF's P/E ratio is 19.92. In terms of profitability, ALPMY's ROE is +0.20%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, ALPMY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check RHHVF's competition here
ALPMY vs AZNCF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, ALPMY is priced at $15.10, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, ALPMY's ROE is +0.20%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, ALPMY is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check AZNCF's competition here
ALPMY vs NVSEF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, NVSEF has a market cap of 276.7B. Regarding current trading prices, ALPMY is priced at $15.10, while NVSEF trades at $145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas NVSEF's P/E ratio is 20.31. In terms of profitability, ALPMY's ROE is +0.20%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, ALPMY is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check NVSEF's competition here
ALPMY vs SNYNF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, SNYNF has a market cap of 114.1B. Regarding current trading prices, ALPMY is priced at $15.10, while SNYNF trades at $95.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas SNYNF's P/E ratio is 20.53. In terms of profitability, ALPMY's ROE is +0.20%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, ALPMY is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check SNYNF's competition here
ALPMY vs GLAXF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, GLAXF has a market cap of 105.4B. Regarding current trading prices, ALPMY is priced at $15.10, while GLAXF trades at $26.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas GLAXF's P/E ratio is 14.12. In terms of profitability, ALPMY's ROE is +0.20%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, ALPMY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check GLAXF's competition here
ALPMY vs CHGCF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, CHGCF has a market cap of 78.9B. Regarding current trading prices, ALPMY is priced at $15.10, while CHGCF trades at $45.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas CHGCF's P/E ratio is 28.88. In terms of profitability, ALPMY's ROE is +0.20%, compared to CHGCF's ROE of +0.23%. Regarding short-term risk, ALPMY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check CHGCF's competition here
ALPMY vs CHGCY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, CHGCY has a market cap of 76.5B. Regarding current trading prices, ALPMY is priced at $15.10, while CHGCY trades at $23.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas CHGCY's P/E ratio is 27.99. In terms of profitability, ALPMY's ROE is +0.20%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, ALPMY is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CHGCY's competition here
ALPMY vs BAYRY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, BAYRY has a market cap of 43.9B. Regarding current trading prices, ALPMY is priced at $15.10, while BAYRY trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas BAYRY's P/E ratio is -10.33. In terms of profitability, ALPMY's ROE is +0.20%, compared to BAYRY's ROE of -0.12%. Regarding short-term risk, ALPMY is less volatile compared to BAYRY. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check BAYRY's competition here
ALPMY vs OTSKY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, OTSKY has a market cap of 35B. Regarding current trading prices, ALPMY is priced at $15.10, while OTSKY trades at $33.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas OTSKY's P/E ratio is 15.42. In terms of profitability, ALPMY's ROE is +0.20%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, ALPMY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OTSKY's competition here
ALPMY vs OTSKF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, OTSKF has a market cap of 34.1B. Regarding current trading prices, ALPMY is priced at $15.10, while OTSKF trades at $64.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas OTSKF's P/E ratio is 15.02. In terms of profitability, ALPMY's ROE is +0.20%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, ALPMY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OTSKF's competition here
ALPMY vs DSKYF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, DSKYF has a market cap of 30.5B. Regarding current trading prices, ALPMY is priced at $15.10, while DSKYF trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas DSKYF's P/E ratio is 17.53. In terms of profitability, ALPMY's ROE is +0.20%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, ALPMY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check DSKYF's competition here
ALPMY vs DSNKY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, DSNKY has a market cap of 30.1B. Regarding current trading prices, ALPMY is priced at $15.10, while DSNKY trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas DSNKY's P/E ratio is 17.29. In terms of profitability, ALPMY's ROE is +0.20%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, ALPMY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check DSNKY's competition here
ALPMY vs ALPMF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, ALPMF has a market cap of 27.9B. Regarding current trading prices, ALPMY is priced at $15.10, while ALPMF trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas ALPMF's P/E ratio is 35.45. In terms of profitability, ALPMY's ROE is +0.20%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, ALPMY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check ALPMF's competition here
ALPMY vs ORINY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, ORINY has a market cap of 22.3B. Regarding current trading prices, ALPMY is priced at $15.10, while ORINY trades at $39.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas ORINY's P/E ratio is 18.01. In terms of profitability, ALPMY's ROE is +0.20%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, ALPMY is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check ORINY's competition here
ALPMY vs GIKLY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, GIKLY has a market cap of 15.1B. Regarding current trading prices, ALPMY is priced at $15.10, while GIKLY trades at $5.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas GIKLY's P/E ratio is 16.40. In terms of profitability, ALPMY's ROE is +0.20%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, ALPMY is less volatile compared to GIKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check GIKLY's competition here
ALPMY vs CSPCY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, CSPCY has a market cap of 13.1B. Regarding current trading prices, ALPMY is priced at $15.10, while CSPCY trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas CSPCY's P/E ratio is 22.60. In terms of profitability, ALPMY's ROE is +0.20%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, ALPMY is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check CSPCY's competition here
ALPMY vs CHJTF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, ALPMY is priced at $15.10, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, ALPMY's ROE is +0.20%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, ALPMY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CHJTF's competition here
ALPMY vs ORINF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, ALPMY is priced at $15.10, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas ORINF's P/E ratio is 18.81. In terms of profitability, ALPMY's ROE is +0.20%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, ALPMY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check ORINF's competition here
ALPMY vs RCDTF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, RCDTF has a market cap of 10B. Regarding current trading prices, ALPMY is priced at $15.10, while RCDTF trades at $55.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas RCDTF's P/E ratio is 19.76. In terms of profitability, ALPMY's ROE is +0.20%, compared to RCDTF's ROE of +0.23%. Regarding short-term risk, ALPMY is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check RCDTF's competition here
ALPMY vs GIFLF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, GIFLF has a market cap of 8.8B. Regarding current trading prices, ALPMY is priced at $15.10, while GIFLF trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas GIFLF's P/E ratio is 18.70. In terms of profitability, ALPMY's ROE is +0.20%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check GIFLF's competition here
ALPMY vs GIFOF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, ALPMY is priced at $15.10, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas GIFOF's P/E ratio is 12.83. In terms of profitability, ALPMY's ROE is +0.20%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check GIFOF's competition here
ALPMY vs OPHLF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, ALPMY is priced at $15.10, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas OPHLF's P/E ratio is 20.79. In terms of profitability, ALPMY's ROE is +0.20%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OPHLF's competition here
ALPMY vs OPHLY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, OPHLY has a market cap of 6.7B. Regarding current trading prices, ALPMY is priced at $15.10, while OPHLY trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas OPHLY's P/E ratio is 20.74. In terms of profitability, ALPMY's ROE is +0.20%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check OPHLY's competition here
ALPMY vs KYKOF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, KYKOF has a market cap of 6.7B. Regarding current trading prices, ALPMY is priced at $15.10, while KYKOF trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas KYKOF's P/E ratio is 16.05. In terms of profitability, ALPMY's ROE is +0.20%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, ALPMY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check KYKOF's competition here
ALPMY vs DPHAY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, ALPMY is priced at $15.10, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, ALPMY's ROE is +0.20%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, ALPMY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check DPHAY's competition here
ALPMY vs VRBCF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, VRBCF has a market cap of 3.6B. Regarding current trading prices, ALPMY is priced at $15.10, while VRBCF trades at $431.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas VRBCF's P/E ratio is 20.37. In terms of profitability, ALPMY's ROE is +0.20%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, ALPMY is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check VRBCF's competition here
ALPMY vs SNPHF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, ALPMY is priced at $15.10, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas SNPHF's P/E ratio is 18.95. In terms of profitability, ALPMY's ROE is +0.20%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, ALPMY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check SNPHF's competition here
ALPMY vs SNPHY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, SNPHY has a market cap of 3.3B. Regarding current trading prices, ALPMY is priced at $15.10, while SNPHY trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas SNPHY's P/E ratio is 17.74. In terms of profitability, ALPMY's ROE is +0.20%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, ALPMY is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check SNPHY's competition here
ALPMY vs HAWPY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, ALPMY is priced at $15.10, while HAWPY trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas HAWPY's P/E ratio is 14.48. In terms of profitability, ALPMY's ROE is +0.20%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, ALPMY is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check HAWPY's competition here
ALPMY vs PTKFF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, PTKFF has a market cap of 2.7B. Regarding current trading prices, ALPMY is priced at $15.10, while PTKFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas PTKFF's P/E ratio is N/A. In terms of profitability, ALPMY's ROE is +0.20%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, ALPMY is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check PTKFF's competition here
ALPMY vs HAWPF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, ALPMY is priced at $15.10, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, ALPMY's ROE is +0.20%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, ALPMY is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check HAWPF's competition here
ALPMY vs CMOPF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, CMOPF has a market cap of 1.9B. Regarding current trading prices, ALPMY is priced at $15.10, while CMOPF trades at $118.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas CMOPF's P/E ratio is -455.77. In terms of profitability, ALPMY's ROE is +0.20%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, ALPMY is more volatile compared to CMOPF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CMOPF's competition here
ALPMY vs LYPHF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, LYPHF has a market cap of 1.6B. Regarding current trading prices, ALPMY is priced at $15.10, while LYPHF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas LYPHF's P/E ratio is 19.75. In terms of profitability, ALPMY's ROE is +0.20%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, ALPMY is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check LYPHF's competition here
ALPMY vs TGRNF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, ALPMY is priced at $15.10, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, ALPMY's ROE is +0.20%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, ALPMY is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check TGRNF's competition here
ALPMY vs JCRRF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, JCRRF has a market cap of 518.4M. Regarding current trading prices, ALPMY is priced at $15.10, while JCRRF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas JCRRF's P/E ratio is -35.42. In terms of profitability, ALPMY's ROE is +0.20%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, ALPMY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check JCRRF's competition here
ALPMY vs MAYNF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, MAYNF has a market cap of 143M. Regarding current trading prices, ALPMY is priced at $15.10, while MAYNF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas MAYNF's P/E ratio is -2.35. In terms of profitability, ALPMY's ROE is +0.20%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, ALPMY is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check MAYNF's competition here
ALPMY vs PTKFY Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, PTKFY has a market cap of 11.6M. Regarding current trading prices, ALPMY is priced at $15.10, while PTKFY trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas PTKFY's P/E ratio is 11.02. In terms of profitability, ALPMY's ROE is +0.20%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, ALPMY is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check PTKFY's competition here
ALPMY vs PSYGF Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, ALPMY is priced at $15.10, while PSYGF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, ALPMY's ROE is +0.20%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, ALPMY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for ALPMY.Check PSYGF's competition here
ALPMY vs CRXTQ Comparison April 2026
ALPMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALPMY stands at 27B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, ALPMY is priced at $15.10, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALPMY currently has a P/E ratio of 34.20, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, ALPMY's ROE is +0.20%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, ALPMY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for ALPMY.Check CRXTQ's competition here